Article
Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping.
Biomedical chromatography : BMC - 1 Jun 1999
Koch J P, ten Tusscher G W, Koppe J G, Guchelaar H J
Abstract excerpt
In this study the validation of a reversed-phase high-performance liquid chromatography (HPLC) method, with UV-detection, for both caffeine and paraxanthine in human serum is described. This method is feasible for cytochrome P450 1A2 (CYP1A2) phenotyping, according to the results of a pilot study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
